President & CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 37,500 shares of BLFS on 07/16/2020 at an average price of $18.99 a share. The total sale was $712,125.
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation. BioLife Solutions Inc has a market cap of $624.310 million; its shares were traded at around $19.55 with a P/E ratio of 47.68 and P/S ratio of 12.95. BioLife Solutions Inc had annual average EBITDA growth of 10.70% over the past five years. GuruFocus has detected 4 severe warning signs with BioLife Solutions Inc. .
CEO Recent Trades:
- President & CEO Michael Rice sold 37,500 shares of BLFS stock on 07/16/2020 at the average price of $18.99. The price of the stock has increased by 2.95% since.
- President & CEO Michael Rice sold 18,750 shares of BLFS stock on 06/19/2020 at the average price of $16.37. The price of the stock has increased by 19.43% since.
Directors and Officers Recent Trades:
- 10% Owner Partners Master Fund, L Casdin bought 990,583 shares of BLFS stock on 07/02/2020 at the average price of $14.5. The price of the stock has increased by 34.83% since.
- 10% Owner Walter Villiger sold 40,460 shares of BLFS stock on 07/06/2020 at the average price of $18.8. The price of the stock has increased by 3.99% since.
- Director, 10% Owner Thomas Girschweiler sold 305,583 shares of BLFS stock on 07/02/2020 at the average price of $14.5. The price of the stock has increased by 34.83% since.
For the complete insider trading history of BLFS, click here
.
